6.2. Sex Differences in Response to GLP-1 RA Therapy in Type 2 Diabetes and Obesity: Prefential Effects in Subcutaneous vs. Visceral Fat Depot. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.